デフォルト表紙
市場調査レポート
商品コード
1085427

計算生物学の世界市場:タイプ別(細胞・生体シミュレーション、疾患モデリング・シミュレーションアプリケーション)、ツール別、地域別-規模、シェア、展望、機会分析(2022年~2028年)

Computational Biology Market, By Type (Cellular & Biological Simulation, Disease Modeling and Simulation Applications ), By Tools, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 135 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
計算生物学の世界市場:タイプ別(細胞・生体シミュレーション、疾患モデリング・シミュレーションアプリケーション)、ツール別、地域別-規模、シェア、展望、機会分析(2022年~2028年)
出版日: 2022年05月31日
発行: Coherent Market Insights
ページ情報: 英文 135 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

バイオインフォマティクスツールの利用の増加と研究開発への投資の増加は、予測期間中の市場成長を促進すると予想されます。さらに、慢性疾患に苦しむ患者の増加や、データ保存のためのクラウドコンピューティングの採用も、市場成長を後押しすると予想されます。

当レポートでは、世界の計算生物学市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場の内訳:タイプ別
    • 市場の内訳:ツール別
    • 市場の内訳:地域別
    • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主なハイライト
  • 製品発売
  • PEST分析
  • 技術の進歩
  • 規制シナリオ
  • 合併と買収

第4章 世界の計算生物学市場:タイプ別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 細胞・生体シミュレーション
  • 疾患モデリング・シミュレーションアプリケーション

第5章 世界の計算生物学市場:ツール別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • コンテンツ/データベース
  • 分析ソフトウェアとサービス
  • ITインフラストラクチャ(ハードウェア)

第6章 世界の計算生物学市場:地域別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第7章 競合情勢

  • 企業プロファイル
    • Accelrys
    • Certara, LP
    • Chemical Computing Group Inc.
    • Compugen, ltd.
    • Entelos, Inc.(Rosa &Co. LLC)
    • Genedata AG
    • Insilico Biotechnology AG
    • Leadscope, Inc.
    • Nimbus Discovery LLC
    • Rhenovia Pharma SAS
    • Schrodinger
    • Simulation Plus, Inc.

第8章 セクション

目次
Product Code: CMI3915

Computational Biology are used of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques in life sciences. Predictive modeling tools provide vital information for better streamlining of drug development process thus reducing time and increasing efficiency. Increasing use of bioinformatics tools along with increasing investment in research and development is expected to propel the market growth during the forecast period. Furthermore, increasing patient population suffering from chronic diseases, increasing adoption of cloud computing for data storage is also anticipated to assist the growth of the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Computational Biology market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Computational Biology market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Computational Biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Computational Biology market

Detailed Segmentation:

  • Global Computational Biology Market, By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
  • Global Computational Biology Market, By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
  • Global Computational Biology Market, By Region:
  • North America
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Type:
    • Cellular & Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
    • Drug Discovery
    • Drug Development
    • By Tools
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Accelrys *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Certara, L.P.
  • Chemical Computing Group Inc.
  • Compugen, ltd.
  • Entelos, Inc. (Rosa & Co. LLC)
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Discovery LLC
  • Rhenovia Pharma SAS
  • Schrodinger
  • Simulation Plus, Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Tools
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Computational Biology Market, By Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cellular & Biological Simulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others (Transcriptomics/Metabolomic)
  • Disease Modeling and Simulation Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Drug Discovery
    • Drug Development

5. Global Computational Biology Market, By Tools, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Content/Database
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Analysis Software & Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • IT Infrastructure (Hardware)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Computational Biology Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Tools, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • Accelrys
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Certara, L.P.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Chemical Computing Group Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Compugen, ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Entelos, Inc. (Rosa & Co. LLC)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Genedata AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Insilico Biotechnology AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Leadscope, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Nimbus Discovery LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rhenovia Pharma SAS
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Schrodinger
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Simulation Plus, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact